Stay updated with breaking news from Neogenomics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Parkman Healthcare Partners LLC cut its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 3.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 237,762 shares of the medical research company’s stock after selling 8,050 shares during the period. Parkman Healthcare Partners LLC owned 0.19% […] ....
Parkman Healthcare Partners LLC lowered its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 3.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 237,762 shares of the medical research company’s stock after selling 8,050 shares during the quarter. Parkman Healthcare Partners LLC’s holdings in NeoGenomics were worth $3,847,000 as […] ....
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report)’s share price rose 8.8% during trading on Wednesday . The company traded as high as $14.37 and last traded at $14.32. Approximately 505,729 shares changed hands during trading, a decline of 41% from the average daily volume of 858,388 shares. The stock had previously closed at $13.16. Analyst […] ....
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 month […] ....
Mckinley Capital Management LLC increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 32.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 183,610 shares of the medical research company’s stock after acquiring an additional 45,260 shares during the period. Mckinley […] ....